Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients
A completed clinical trial comparing rosuvastatin with the fixed-dose combination of ezetimibe and simvastatin in outpatients with dyslipide…
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome [Phase 3]
Phase 3 trial evaluating nicotinic acid (niacin) for dyslipidemia in metabolic syndrome has completed and reports efficacy data.
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy [Phase 4]
Phase 4 clinical trial evaluating colesevelam for impaired fasting glucose in patients on niacin therapy for dyslipidemia; the study has com…
-
CLINICAL_TRIALS trial_result · 2011-12-23Clinical Trial Update: Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes [Phase 4]
This Phase 4 study evaluated the effects of atorvastatin on hemostasis and skin microcirculation in adults with Type 1 diabetes mellitus and…
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea
A completed clinical trial in Korea assessed how many dyslipidemic patients on lipid-lowering therapy achieved cholesterol goals and what fa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-12Clinical Trial Update: Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand
A completed AstraZeneca-sponsored clinical trial in Thailand evaluated lipid goal attainment and mortality among patients at high cardiovasc…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP [Phase 3]
Phase 3 clinical trial evaluating thyroid hormone replacement with levothyroxine (thyroxin) for subclinical hypothyroidism and its effects o…
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia [Phase 4]
A Phase 4 head-to-head trial comparing rosuvastatin to simvastatin in adults with type 2 diabetes mellitus and dyslipidemia has completed, e…
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: The Roles of SAH Gene Family in Athrogenic Dyslipidemia in Postmenopausal Women
This clinical trial update examines the roles of the SAH gene family in atherogenic dyslipidemia in postmenopausal women. The sponsor is Tai…
-
CLINICAL_TRIALS research · 2011-12-06Clinical Trial Update: Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia [NA]
Clinical trial entry for a traditional Chinese medicine treatment of obesity with type 2 diabetes mellitus and dyslipidemia; sponsor Guang'a…
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: Reduced Cardiac Rehabilitation Program [NA]
A clinical trial update indicating the completion of a study on a reduced cardiac rehabilitation program.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of fluvastatin, valsartan, and their combination in dyslipidemic patients with hyp…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone [Phase 3]
Phase 3 trial comparing the combination of fluvastatin and ezetimibe to fluvastatin alone for dyslipidemia has completed.
-
CLINICAL_TRIALS research · 2011-10-20Clinical Trial Update: Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain
A database analysis of prior Spanish studies evaluated dyslipidemia, risk of atherosclerosis, and inflammatory/oxidative biomarkers (hsCRP) …
-
FDA approval · 2011-10-06FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for ZOCOR (simvastatin) filed by Organon LLC.
-
CLINICAL_TRIALS research · 2011-09-05Clinical Trial Update: A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia [NA]
A large, multi-site, individually randomized trial is evaluating integrated care strategies to reduce cardiovascular disease risk among adul…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia [Phase 4]
This Phase 4 clinical trial compares high-dose rosuvastatin with low-dose statin plus fenofibrate, and low-dose statin plus niacin for mixed…
-
FDA approval · 2011-07-26FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS research · 2011-07-22Clinical Trial Update: Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) [Phase 4]
A Phase 4 clinical trial update evaluating whether adding nicotinic acid to simvastatin improves carotid and femoral intima-media thickness …
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Risk Assessment and Treat Compliance in Hypertension Education Trial [NA]
This update reports on a completed clinical trial focused on risk assessment and treatment compliance in hypertension education.
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics [NA]
This entry summarizes the completion of a University of Aarhus clinical trial studying hepatic insulin sensitivity and VLDL-TG kinetics in p…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating a decision aid for statin use in patients with type 2 diabetes mellitus; the study is completed.
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients [Phase 3]
A Phase 3 study evaluated the metabolic and vascular effects of statins in untreated patients with Type 2 diabetes and diabetic dyslipidemia…
-
FDA approval · 2011-05-08FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate (generic) from Rhodes Pharmaceuticals L.P., granting approval for an ANDA-relate…
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia
A completed trial update describing an education and awareness program to assess adherence to dyslipidemia treatment, sponsored by AstraZene…